Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling.

Autor: Turner JA; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Van Gulick RJ; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Robinson WA; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Mughal T; Division of Hematology-Oncology, Tufts University Cancer Center, Boston, Massachusetts, USA., Tobin RP; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., MacBeth ML; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Holman B; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Classon A; Foundation Medicine Inc., Cambridge, Massachusetts, USA., Bagby SM; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Yacob BW; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Hartman SJ; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Silverman I; Ignyta, Inc., San Diego, California, USA., Vorwald VM; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Gorden N; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Gonzalez R; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Gay LM; Foundation Medicine Inc., Cambridge, Massachusetts, USA., Ali SM; Foundation Medicine Inc., Cambridge, Massachusetts, USA., Benson A; Foundation Medicine Inc., Cambridge, Massachusetts, USA., Miller VA; Foundation Medicine Inc., Cambridge, Massachusetts, USA., Ross JS; Foundation Medicine Inc., Cambridge, Massachusetts, USA.; Department of Pathology, Upstate Medical University, Syracuse, New York, USA., Pitts TM; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Rioth MJ; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Lewis KD; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Medina T; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., McCarter MD; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Gonzalez R; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Couts KL; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Center for Rare Melanomas, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Jul 12. Date of Electronic Publication: 2024 Jul 12.